Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Synopsys- DesignWare DDR PHY IP platform selected by Nvidia » 09:09
05/28/20
05/28
09:09
05/28/20
09:09
SNPS

Synopsys

$170.53 /

+2.02 (+1.20%)

, NVDA

Nvidia

$341.08 /

-7.74 (-2.22%)

Synopsys' (SNPS)…

Synopsys' (SNPS) silicon-proven DesignWare DDR5/4 PHY IP will be used by Mellanox, NVIDIA's (NVDA) networking business unit, to address evolving memory requirements in its InfiniBand networking chips targeting high-performance computing and artificial intelligence applications. Synopsys' DesignWare DDR5/4 PHY IP offers firmware-based training, to help customers reduce their risk of adopting new protocols.

ShowHide Related Items >><<
SNPS Synopsys
$170.53 /

+2.02 (+1.20%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

SNPS Synopsys
$170.53 /

+2.02 (+1.20%)

05/27/20 UBS
Synopsys initiated with a Buy at UBS
05/21/20 Baird
Synopsys price target raised to $193 from $182 at Baird
05/21/20 JPMorgan
Synopsys price target raised to $180 from $160 at JPMorgan
05/21/20 Wells Fargo
Synopsys price target raised to $185 from $180 at Wells Fargo
NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

05/22/20 JPMorgan
Nvidia price target raised to $405 from $305 at JPMorgan
05/22/20 Rosenblatt
Nvidia price target raised to $400 from $340 at Rosenblatt
05/22/20 Raymond James
Nvidia price target raised to $370 from $330 at Raymond James
05/22/20 Craig-Hallum
Nvidia price target raised to $335 from $300 at Craig-Hallum
SNPS Synopsys
$170.53 /

+2.02 (+1.20%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

NVDA Nvidia
$341.08 /

-7.74 (-2.22%)

Over a week ago
Initiation
Synopsys initiated with a Buy at UBS » 06:17
05/27/20
05/27
06:17
05/27/20
06:17
SNPS

Synopsys

$168.51 /

-2.72 (-1.59%)

, CDNS

Cadence Design

$85.01 /

-1.015 (-1.18%)

UBS analyst Pradeep…

UBS analyst Pradeep Ramani initiated coverage of Synopsys (SNPS) with a Buy rating and $209 price target. The analyst cites the company's unique position of delivering "mission-critical" chip-design software to semis vertical with "strong secular underpinnings" in the high-growth areas of Cloud Computing, AI, and 5G. Ramani sees Synopsys as an "entrenched market leader" and well positioned to deliver given the breadth of its software platform and its IP portfolio, even as the stock trades at a 20% discount to peer Cadence Design (CDNS) on enterprise value to sales multiple basis.

ShowHide Related Items >><<
SNPS Synopsys
$168.51 /

-2.72 (-1.59%)

CDNS Cadence Design
$85.01 /

-1.015 (-1.18%)

SNPS Synopsys
$168.51 /

-2.72 (-1.59%)

05/21/20 Baird
Synopsys price target raised to $193 from $182 at Baird
05/21/20 JPMorgan
Synopsys price target raised to $180 from $160 at JPMorgan
05/21/20 Wells Fargo
Synopsys price target raised to $185 from $180 at Wells Fargo
05/21/20 Benchmark
Synopsys price target raised to $190 from $150 at Benchmark
CDNS Cadence Design
$85.01 /

-1.015 (-1.18%)

04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
04/22/20 BofA
Cadence Design upgraded to Buy from Neutral at BofA
04/21/20 Baird
Cadence Design price target raised to $91 from $72 at Baird
02/18/20 Baird
Cadence Design initiated with an Outperform at Baird
SNPS Synopsys
$168.51 /

-2.72 (-1.59%)

CDNS Cadence Design
$85.01 /

-1.015 (-1.18%)

CDNS Cadence Design
$85.01 /

-1.015 (-1.18%)

Recommendations
Synopsys price target raised to $193 from $182 at Baird » 09:23
05/21/20
05/21
09:23
05/21/20
09:23
SNPS

Synopsys

$165.52 /

+3.48 (+2.15%)

Baird analyst Joe Vruwink…

Baird analyst Joe Vruwink raised the firm's price target on Synopsys to $193 from $182 and keeps an Outperform rating on the shares. The analyst believes they are well positioned to deliver strong revenue growth and margin expansion, helping the stock to outperform. He remains a buyer and continues to like the upside case for the shares.

ShowHide Related Items >><<
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

05/21/20 JPMorgan
Synopsys price target raised to $180 from $160 at JPMorgan
05/21/20 Wells Fargo
Synopsys price target raised to $185 from $180 at Wells Fargo
05/21/20 Benchmark
Synopsys price target raised to $190 from $150 at Benchmark
05/21/20 RBC Capital
Synopsys price target raised to $185 from $178 at RBC Capital
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

Recommendations
Synopsys price target raised to $180 from $160 at JPMorgan » 08:42
05/21/20
05/21
08:42
05/21/20
08:42
SNPS

Synopsys

$165.52 /

+3.48 (+2.15%)

JPMorgan analyst Jackson…

JPMorgan analyst Jackson Ader raised the firm's price target on Synopsys to $180 from $160 and keeps an Overweight rating on the shares following the company's better than expected Q2 results. The margin expansion story remains intact and cash flow for the year was guided higher with collections remaining strong, Ader tells investors in a research note.

ShowHide Related Items >><<
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

05/21/20 Wells Fargo
Synopsys price target raised to $185 from $180 at Wells Fargo
05/21/20 Benchmark
Synopsys price target raised to $190 from $150 at Benchmark
05/21/20 RBC Capital
Synopsys price target raised to $185 from $178 at RBC Capital
05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

Recommendations
Synopsys price target raised to $185 from $180 at Wells Fargo » 08:27
05/21/20
05/21
08:27
05/21/20
08:27
SNPS

Synopsys

$165.52 /

+3.48 (+2.15%)

Wells Fargo analyst Gary…

Wells Fargo analyst Gary Mobley raised the firm's price target on Synopsys to $185 from $180 and keeps an Overweight rating on the shares. The analyst cites a "notable beat" for Q2 and fiscal year 2020 revenue/EPS guidance that remains unchanged from beginning-year guidance, perhaps indicating some pull-forward of emulation tool sales.

ShowHide Related Items >><<
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

05/21/20 Benchmark
Synopsys price target raised to $190 from $150 at Benchmark
05/21/20 RBC Capital
Synopsys price target raised to $185 from $178 at RBC Capital
05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

Recommendations
Synopsys price target raised to $190 from $150 at Benchmark » 07:20
05/21/20
05/21
07:20
05/21/20
07:20
SNPS

Synopsys

$165.52 /

+3.48 (+2.15%)

Benchmark analyst Ruben…

Benchmark analyst Ruben Roy raised the firm's price target on Synopsys to $190 from $150 and keeps a Buy rating on the shares after the company reported strong Q2 results, reaffirmed fiscal year revenue guidance and increased its full year non-GAAP EPS outlook. Synopsys said customer engagements and design activity remained robust despite the pandemic and Roy believes that design activity is likely to remain robust given medium-term demand from markets such as data center/cloud and 5G, the analyst tells investors.

ShowHide Related Items >><<
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

05/21/20 RBC Capital
Synopsys price target raised to $185 from $178 at RBC Capital
05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
02/20/20 DA Davidson
Synopsys price target raised to $200 from $175 at DA Davidson
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

Recommendations
Synopsys price target raised to $185 from $178 at RBC Capital » 06:35
05/21/20
05/21
06:35
05/21/20
06:35
SNPS

Synopsys

$165.52 /

+3.48 (+2.15%)

RBC Capital analyst Mitch…

RBC Capital analyst Mitch Steves raised the firm's price target on Synopsys to $185 from $178 and keeps an Outperform rating on the shares. The company's "beat and raise" Q2 results and FY20 guidance is "rare" for the current macro environment but a "common theme" in Electronic Design Automation, the analyst tells investors in a research note. Steves adds that the management is still being conservative in its outlook and believes that the elevated design activity will result in more upside this year.

ShowHide Related Items >><<
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
02/20/20 DA Davidson
Synopsys price target raised to $200 from $175 at DA Davidson
02/20/20 Credit Suisse
Synopsys price target raised to $180 from $150 at Credit Suisse
SNPS Synopsys
$165.52 /

+3.48 (+2.15%)

Earnings
Synopsys sees FY20 adjusted EPS $5.21-$5.28, consensus $5.18 » 16:07
05/20/20
05/20
16:07
05/20/20
16:07
SNPS

Synopsys

$165.63 /

+3.59 (+2.22%)

Sees FY20 revenue…

Sees FY20 revenue $3.6B-$3.65B, consensus $3.63B.

ShowHide Related Items >><<
SNPS Synopsys
$165.63 /

+3.59 (+2.22%)

SNPS Synopsys
$165.63 /

+3.59 (+2.22%)

05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
02/20/20 DA Davidson
Synopsys price target raised to $200 from $175 at DA Davidson
02/20/20 Credit Suisse
Synopsys price target raised to $180 from $150 at Credit Suisse
SNPS Synopsys
$165.63 /

+3.59 (+2.22%)

Earnings
Synopsys sees Q3 adjusted EPS $1.33-$1.38, consensus $1.47 » 16:06
05/20/20
05/20
16:06
05/20/20
16:06
SNPS

Synopsys

$165.89 /

+3.85 (+2.38%)

Sees Q3 revenue…

Sees Q3 revenue $875M-$905M, consensus $948.71M.

ShowHide Related Items >><<
SNPS Synopsys
$165.89 /

+3.85 (+2.38%)

SNPS Synopsys
$165.89 /

+3.85 (+2.38%)

05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
02/20/20 DA Davidson
Synopsys price target raised to $200 from $175 at DA Davidson
02/20/20 Credit Suisse
Synopsys price target raised to $180 from $150 at Credit Suisse
SNPS Synopsys
$165.89 /

+3.85 (+2.38%)

Earnings
Synopsys reports Q2 adjusted EPS $1.22, consensus 98c » 16:05
05/20/20
05/20
16:05
05/20/20
16:05
SNPS

Synopsys

$165.98 /

+3.94 (+2.43%)

Reports Q2 revenue…

Reports Q2 revenue $861.3M, consensus $837.28M.

ShowHide Related Items >><<
SNPS Synopsys
$165.98 /

+3.94 (+2.43%)

SNPS Synopsys
$165.98 /

+3.94 (+2.43%)

05/15/20 Baird
Synopsys remains a top idea ahead of results, says Baird
04/22/20 BofA
Cadence Design upgraded to Buy on dependability at BofA
02/20/20 DA Davidson
Synopsys price target raised to $200 from $175 at DA Davidson
02/20/20 Credit Suisse
Synopsys price target raised to $180 from $150 at Credit Suisse
SNPS Synopsys
$165.98 /

+3.94 (+2.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.